Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 68

1.

Association between phosphodiesterase type 5 inhibitors and prostate cancer: A systematic review.

Aoun F, Slaoui A, Walid AHO, Albisinni S, Assenmacher G, de Plaen E, Azzo JM, Peltier A, Roumeguère T.

Prog Urol. 2018 Oct;28(12):560-566. doi: 10.1016/j.purol.2018.07.004. Epub 2018 Sep 7.

PMID:
30201551
2.

[Pleuroperitoneal communication: pleural effusion subsequent to the initiation of peritoneal dialysis, about a case].

De Plaen E, Therasse A, Lebrun E, Mestrez F, Binet L, Lemaitre J.

Rev Med Brux. 2017;38(1):33-35. French.

PMID:
28525199
3.

microRNA-155, induced by interleukin-1ß, represses the expression of microphthalmia-associated transcription factor (MITF-M) in melanoma cells.

Arts N, Cané S, Hennequart M, Lamy J, Bommer G, Van den Eynde B, De Plaen E.

PLoS One. 2015 Apr 8;10(4):e0122517. doi: 10.1371/journal.pone.0122517. eCollection 2015.

4.

Intramuscular electroporation of a P1A-encoding plasmid vaccine delays P815 mastocytoma growth.

Vandermeulen G, Uyttenhove C, De Plaen E, Van den Eynde BJ, Préat V.

Bioelectrochemistry. 2014 Dec;100:112-8. doi: 10.1016/j.bioelechem.2013.11.002. Epub 2013 Dec 1.

PMID:
24342164
5.

Reversal of tumoral immune resistance by inhibition of tryptophan 2,3-dioxygenase.

Pilotte L, Larrieu P, Stroobant V, Colau D, Dolusic E, Frédérick R, De Plaen E, Uyttenhove C, Wouters J, Masereel B, Van den Eynde BJ.

Proc Natl Acad Sci U S A. 2012 Feb 14;109(7):2497-502. doi: 10.1073/pnas.1113873109. Epub 2012 Jan 30.

6.

Interleukins 1alpha and 1beta secreted by some melanoma cell lines strongly reduce expression of MITF-M and melanocyte differentiation antigens.

Kholmanskikh O, van Baren N, Brasseur F, Ottaviani S, Vanacker J, Arts N, van der Bruggen P, Coulie P, De Plaen E.

Int J Cancer. 2010 Oct 1;127(7):1625-36. doi: 10.1002/ijc.25182.

7.

Expression of BORIS in melanoma: lack of association with MAGE-A1 activation.

Kholmanskikh O, Loriot A, Brasseur F, De Plaen E, De Smet C.

Int J Cancer. 2008 Feb 15;122(4):777-84.

8.

A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma.

van der Bruggen P, Traversari C, Chomez P, Lurquin C, De Plaen E, Van den Eynde BJ, Knuth A, Boon T.

J Immunol. 2007 Mar 1;178(5):2617-21. No abstract available.

9.

Noxp20 and Noxp70, two new markers of early neuronal differentiation, detected in teratocarcinoma-derived neuroectodermic precursor cells.

Boucquey M, De Plaen E, Locker M, Poliard A, Mouillet-Richard S, Boon T, Kellermann O.

J Neurochem. 2006 Oct;99(2):657-69.

10.

Transient down-regulation of DNMT1 methyltransferase leads to activation and stable hypomethylation of MAGE-A1 in melanoma cells.

Loriot A, De Plaen E, Boon T, De Smet C.

J Biol Chem. 2006 Apr 14;281(15):10118-26. Epub 2006 Feb 22.

11.

Unambiguous identification of the expressed MAGE-A genes on a DNA microarray.

Zammatteo N, Davril C, Brasseur F, Hamels S, De Plaen E, Boon T, Remacle J.

Clin Chem. 2005 Dec;51(12):2420-1. No abstract available.

12.

Contrasting frequencies of antitumor and anti-vaccine T cells in metastases of a melanoma patient vaccinated with a MAGE tumor antigen.

Lurquin C, Lethé B, De Plaen E, Corbière V, Théate I, van Baren N, Coulie PG, Boon T.

J Exp Med. 2005 Jan 17;201(2):249-57.

13.

High frequency of antitumor T cells in the blood of melanoma patients before and after vaccination with tumor antigens.

Germeau C, Ma W, Schiavetti F, Lurquin C, Henry E, Vigneron N, Brasseur F, Lethé B, De Plaen E, Velu T, Boon T, Coulie PG.

J Exp Med. 2005 Jan 17;201(2):241-8.

14.

A novel approach to identify antigens recognized by CD4 T cells using complement-opsonized bacteria expressing a cDNA library.

van de Corput L, Chaux P, van der Meijden ED, De Plaen E, Frederik Falkenburg JH, van der Bruggen P.

Leukemia. 2005 Feb;19(2):279-85.

PMID:
15526018
15.

MAGE-A1 interacts with adaptor SKIP and the deacetylase HDAC1 to repress transcription.

Laduron S, Deplus R, Zhou S, Kholmanskikh O, Godelaine D, De Smet C, Hayward SD, Fuks F, Boon T, De Plaen E.

Nucleic Acids Res. 2004 Aug 17;32(14):4340-50. Print 2004.

16.

A gene expressed exclusively in acute B lymphoblastic leukemias.

Vialle-Castellano A, Laduron S, De Plaen E, Jost E, Dupont S, Ameye G, Michaux L, Coulie P, Olive D, Boon T, van Baren N.

Genomics. 2004 Jan;83(1):85-94.

PMID:
14667812
17.

A new tumor-specific antigenic peptide encoded by MAGE-6 is presented to cytolytic T lymphocytes by HLA-Cw16.

Vantomme V, Boël P, De Plaen E, Boon T, van der Bruggen P.

Cancer Immun. 2003 Dec 10;3:17.

18.

DNA microarray to monitor the expression of MAGE-A genes.

Zammatteo N, Lockman L, Brasseur F, De Plaen E, Lurquin C, Lobert PE, Hamels S, Boon T, Remacle J.

Clin Chem. 2002 Jan;48(1):25-34.

19.

An overview of the MAGE gene family with the identification of all human members of the family.

Chomez P, De Backer O, Bertrand M, De Plaen E, Boon T, Lucas S.

Cancer Res. 2001 Jul 15;61(14):5544-51.

20.

Induction of cytolytic T lymphocytes by immunization of mice with an adenovirus containing a mouse homolog of the human MAGE-A genes.

Van Pel A, De Plaen E, Duffour MT, Warnier G, Uyttenhove C, Perricaudet M, Boon T.

Cancer Immunol Immunother. 2001 Jan;49(11):593-602.

PMID:
11225990
21.

Identification on a human sarcoma of two new genes with tumor-specific expression.

Martelange V, De Smet C, De Plaen E, Lurquin C, Boon T.

Cancer Res. 2000 Jul 15;60(14):3848-55.

22.

Cell- and stage-specific expression of mage genes during mouse spermatogenesis.

Clotman F, De Backer O, De Plaen E, Boon T, Picard J.

Mamm Genome. 2000 Aug;11(8):696-9. No abstract available.

PMID:
10920243
23.
24.

Two antigens recognized by autologous cytolytic T lymphocytes on a melanoma result from a single point mutation in an essential housekeeping gene.

Chiari R, Foury F, De Plaen E, Baurain JF, Thonnard J, Coulie PG.

Cancer Res. 1999 Nov 15;59(22):5785-92.

25.

Quantitative evaluation of the expression of MAGE genes in tumors by limiting dilution of cDNA libraries.

Serrano A, Lethé B, Delroisse JM, Lurquin C, De Plaen E, Brasseur F, Rimoldi D, Boon T.

Int J Cancer. 1999 Nov 26;83(5):664-9.

26.

cDNA and protein characterization of human MAGE-10.

Rimoldi D, Salvi S, Reed D, Coulie P, Jongeneel VC, De Plaen E, Brasseur F, Rodriguez AM, Boon T, Cerottini JC.

Int J Cancer. 1999 Sep 9;82(6):901-7.

27.

Characterization of the GAGE genes that are expressed in various human cancers and in normal testis.

De Backer O, Arden KC, Boretti M, Vantomme V, De Smet C, Czekay S, Viars CS, De Plaen E, Brasseur F, Chomez P, Van den Eynde B, Boon T, van der Bruggen P.

Cancer Res. 1999 Jul 1;59(13):3157-65.

28.

Cytolytic T lymphocytes recognize an antigen encoded by MAGE-A10 on a human melanoma.

Huang LQ, Brasseur F, Serrano A, De Plaen E, van der Bruggen P, Boon T, Van Pel A.

J Immunol. 1999 Jun 1;162(11):6849-54.

29.

A new family of mouse genes homologous to the human MAGE genes.

De Plaen E, De Backer O, Arnaud D, Bonjean B, Chomez P, Martelange V, Avner P, Baldacci P, Babinet C, Hwang SY, Knowles B, Boon T.

Genomics. 1999 Jan 15;55(2):176-84.

PMID:
9933564
30.

LAGE-1, a new gene with tumor specificity.

Lethé B, Lucas S, Michaux L, De Smet C, Godelaine D, Serrano A, De Plaen E, Boon T.

Int J Cancer. 1998 Jun 10;76(6):903-8.

31.

Two members of the human MAGEB gene family located in Xp21.3 are expressed in tumors of various histological origins.

Lurquin C, De Smet C, Brasseur F, Muscatelli F, Martelange V, De Plaen E, Brasseur R, Monaco AP, Boon T.

Genomics. 1997 Dec 15;46(3):397-408.

PMID:
9441743
32.

Identification of genes coding for tumor antigens recognized by cytolytic T lymphocytes.

De Plaen E, Lurquin C, Lethé B, van der Bruggen P, Brichard V, Renauld JC, Coulie P, Van Pel A, Boon T.

Methods. 1997 Jun;12(2):125-42. Review.

PMID:
9184377
33.

Alternative promoters of gene MAGE4a.

De Plaen E, Naerhuyzen B, De Smet C, Szikora JP, Boon T.

Genomics. 1997 Mar 1;40(2):305-13.

PMID:
9119398
34.

Genes coding for melanoma antigens recognised by cytolytic T lymphocytes.

De Smet C, Lurquin C, De Plaen E, Brasseur F, Zarour H, De Backer O, Coulie PG, Boon T.

Eye (Lond). 1997;11 ( Pt 2):243-8. Review.

PMID:
9349420
35.

A peptide recognized by human cytolytic T lymphocytes on HLA-A2 melanomas is encoded by an intron sequence of the N-acetylglucosaminyltransferase V gene.

Guilloux Y, Lucas S, Brichard VG, Van Pel A, Viret C, De Plaen E, Brasseur F, Lethé B, Jotereau F, Boon T.

J Exp Med. 1996 Mar 1;183(3):1173-83.

36.

A p16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma.

Wölfel T, Hauer M, Schneider J, Serrano M, Wölfel C, Klehmann-Hieb E, De Plaen E, Hankeln T, Meyer zum Büschenfelde KH, Beach D.

Science. 1995 Sep 1;269(5228):1281-4.

PMID:
7652577
37.

Structure, chromosomal location, and expression pattern of three mouse genes homologous to the human MAGE genes.

De Backer O, Verheyden AM, Martin B, Godelaine D, De Plaen E, Brasseur R, Avner P, Boon T.

Genomics. 1995 Jul 1;28(1):74-83.

PMID:
7590750
38.

Isolation and characterization of a MAGE gene family in the Xp21.3 region.

Muscatelli F, Walker AP, De Plaen E, Stafford AN, Monaco AP.

Proc Natl Acad Sci U S A. 1995 May 23;92(11):4987-91.

39.
40.

An intracisternal A-particle sequence codes for an antigen recognized by syngeneic cytolytic T lymphocytes on a mouse spontaneous leukemia.

de Bergeyck V, De Plaen E, Chomez P, Boon T, Van Pel A.

Eur J Immunol. 1994 Sep;24(9):2203-12.

PMID:
8088336
41.

A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas.

Coulie PG, Brichard V, Van Pel A, Wölfel T, Schneider J, Traversari C, Mattei S, De Plaen E, Lurquin C, Szikora JP, Renauld JC, Boon T.

J Exp Med. 1994 Jul 1;180(1):35-42.

42.

Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes.

Gaugler B, Van den Eynde B, van der Bruggen P, Romero P, Gaforio JJ, De Plaen E, Lethé B, Brasseur F, Boon T.

J Exp Med. 1994 Mar 1;179(3):921-30.

43.

Sequence and expression pattern of the human MAGE2 gene.

De Smet C, Lurquin C, van der Bruggen P, De Plaen E, Brasseur F, Boon T.

Immunogenetics. 1994;39(2):121-9.

PMID:
8276455
44.

Structure, chromosomal localization, and expression of 12 genes of the MAGE family.

De Plaen E, Arden K, Traversari C, Gaforio JJ, Szikora JP, De Smet C, Brasseur F, van der Bruggen P, Lethé B, Lurquin C, et al.

Immunogenetics. 1994;40(5):360-9.

PMID:
7927540
45.

Genes coding for tumor-specific rejection antigens.

Boon T, Van den Eynde B, Hirsch H, Moroni C, De Plaen E, van der Bruggen P, De Smet C, Lurquin C, Szikora JP, De Backer O.

Cold Spring Harb Symp Quant Biol. 1994;59:617-22. No abstract available.

PMID:
7587121
46.

The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas.

Brichard V, Van Pel A, Wölfel T, Wölfel C, De Plaen E, Lethé B, Coulie P, Boon T.

J Exp Med. 1993 Aug 1;178(2):489-95.

47.

Genes coding for tumor antigens recognized by human cytolytic T lymphocytes.

Coulie PG, Weynants P, Lehmann F, Herman J, Brichard V, Wölfel T, Van Pel A, De Plaen E, Brasseur F, Boon T.

J Immunother Emphasis Tumor Immunol. 1993 Aug;14(2):104-9. Review.

PMID:
8280701
48.

The tum- antigens P91A and P198 derive from proteins located in the cytosolic compartment of cells.

Verlant V, Amar-Costesec A, Godelaine D, Turu C, Van Pel A, De Plaen E, Dautry-Varsat A, Beaufay H.

Eur J Immunol. 1993 Jul;23(7):1727-30.

PMID:
8325344
49.

A tumour-associated antigen expression in human haematological malignancies.

Chambost H, Brasseur F, Coulie P, de Plaen E, Stoppa AM, Baume D, Mannoni P, Boon T, Maraninchi D, Olive D.

Br J Haematol. 1993 Jul;84(3):524-6.

PMID:
8217804
50.

A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E.

Traversari C, van der Bruggen P, Luescher IF, Lurquin C, Chomez P, Van Pel A, De Plaen E, Amar-Costesec A, Boon T.

J Exp Med. 1992 Nov 1;176(5):1453-7.

Supplemental Content

Loading ...
Support Center